Blockchain Registration Transaction Record
Silo Pharma Collaborates with Veloxity Labs for Ongoing Study of PTSD Treatment SPC-15
Silo Pharma partners with Veloxity Labs for GLP-compliant bioanalysis of PTSD treatment SPC-15. Collaboration aims to advance innovative therapies for stress-induced psychiatric disorders and chronic pain. Exciting developments in the biopharmaceutical industry.

This news matters as it highlights the progress of Silo Pharma in developing innovative treatments for stress-induced psychiatric disorders and chronic pain conditions. The partnership with Veloxity Labs signifies a significant step towards potentially addressing PTSD with the intranasal treatment SPC-15, offering hope for individuals suffering from these conditions.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xa8f77beb4503f14ac63dbc9b6b19e6df70763b67f61ba2fb8b55f3b8b7949ced |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | envy3Upz-eee9609d93465c50d23fa08426915ad0 |